VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA (English)
- New search for: Martin, L. K.
- New search for: Li, X.
- New search for: Kleiber, B.
- New search for: Ellison, E. C.
- New search for: Bloomston, M.
- New search for: Zalupski, M.
- New search for: Bekaii-Saab, T. S.
- New search for: Martin, L. K.
- New search for: Li, X.
- New search for: Kleiber, B.
- New search for: Ellison, E. C.
- New search for: Bloomston, M.
- New search for: Zalupski, M.
- New search for: Bekaii-Saab, T. S.
In:
ANNALS OF ONCOLOGY
;
23
, 11
;
2812-2820
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA
-
Contributors:Martin, L. K. ( author ) / Li, X. ( author ) / Kleiber, B. ( author ) / Ellison, E. C. ( author ) / Bloomston, M. ( author ) / Zalupski, M. ( author ) / Bekaii-Saab, T. S. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 23, 11 ; 2812-2820
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2012-01-01
-
Size:9 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 23, Issue 11
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2775
-
Hope: oncologys missing breakthroughCorn, B. W. et al. | 2012
- 2776
-
Adjuvant therapy in primary GIST: state-of-the-artReichardt, P. / Blay, J. Y. / Boukovinas, I. / Brodowicz, T. / Broto, J. M. / Casali, P. G. / Decatris, M. / Eriksson, M. / Gelderblom, H. / Kosmidis, P. et al. | 2012
- 2782
-
The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasisHadji, P. / Coleman, R. / Gnant, M. / Green, J. et al. | 2012
- 2791
-
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysisTramacere, I. / Pelucchi, C. / Bonifazi, M. / Bagnardi, V. / Rota, M. / Bellocco, R. / Scotti, L. / Islami, F. / Corrao, G. / Boffetta, P. et al. | 2012
- 2799
-
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancerGoncalves, A. / Gilabert, M. / Francois, E. / Dahan, L. / Perrier, H. / Lamy, R. / Re, D. / Largillier, R. / Gasmi, M. / Tchiknavorian, X. et al. | 2012
- 2805
-
Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlandsvan Steenbergen, L. N. / Lemmens, V. E. / Rutten, H. J. / Wymenga, A. N. / Nortier, J. W. / Janssen-Heijnen, M. L. et al. | 2012
- 2812
-
VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCAMartin, L. K. / Li, X. / Kleiber, B. / Ellison, E. C. / Bloomston, M. / Zalupski, M. / Bekaii-Saab, T. S. et al. | 2012
- 2820
-
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinomaPipas, J. M. / Zaki, B. I. / McGowan, M. M. / Tsapakos, M. J. / Ripple, G. H. / Suriawinata, A. A. / Tsongalis, G. J. / Colacchio, T. A. / Gordon, S. R. / Sutton, J. E. et al. | 2012
- 2827
-
Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)daggerThuss-Patience, P. C. / Hofheinz, R. D. / Arnold, D. / Florschutz, A. / Daum, S. / Kretzschmar, A. / Mantovani-Loffler, L. / Bichev, D. / Breithaupt, K. / Kneba, M. et al. | 2012
- 2834
-
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancerKindler, H. L. / Richards, D. A. / Garbo, L. E. / Garon, E. B. / Stephenson, J. J. / Rocha-Lima, C. M. / Safran, H. / Chan, D. / Kocs, D. M. / Galimi, F. et al. | 2012
- 2843
-
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trialsHuober, J. / Gelber, S. / Goldhirsch, A. / Coates, A. S. / Viale, G. / Ohlschlegel, C. / Price, K. N. / Gelber, R. D. / Regan, M. M. / Thurlimann, B. et al. | 2012
- 2852
-
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group reportKarlsson, P. / Cole, B. F. / Chua, B. H. / Price, K. N. / Lindtner, J. / Collins, J. P. / Kovacs, A. / Thurlimann, B. / Crivellari, D. / Castiglione-Gertsch, M. et al. | 2012
- 2859
-
Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancerTruin, W. / Voogd, A. C. / Vreugdenhil, G. / van der Heiden-van der Loo, M. / Siesling, S. / Roumen, R. M. et al. | 2012
- 2866
-
Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifenPrat, A. / Parker, J. S. / Fan, C. / Cheang, M. C. / Miller, L. D. / Bergh, J. / Chia, S. K. / Bernard, P. S. / Nielsen, T. O. / Ellis, M. J. et al. | 2012
- 2873
-
Explanatory factors of sexual function in sexual minority women breast cancer survivorsBoehmer, U. / Timm, A. / Ozonoff, A. / Potter, J. et al. | 2012
- 2879
-
Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patientsKluger, N. / Jacot, W. / Frouin, E. / Rigau, V. / Poujol, S. / Dereure, O. / Guillot, B. / Romieu, G. / Bessis, D. et al. | 2012
- 2884
-
Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastasesMunzone, E. / Botteri, E. / Esposito, A. / Sciandivasci, A. / Franchi, D. / Pruneri, G. / Rotmensz, N. / Curigliano, G. / Adamoli, L. / Bocciolone, L. et al. | 2012
- 2890
-
Post-cancer fatigue is not associated with immune activation or altered cytokine productionCameron, B. A. / Bennett, B. / Li, H. / Boyle, F. / deSouza, P. / Wilcken, N. / Friedlander, M. / Goldstein, D. / Lloyd, A. R. et al. | 2012
- 2896
-
A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel studyReyners, A. K. / de Munck, L. / Erdkamp, F. L. / Smit, W. M. / Hoekman, K. / Lalisang, R. I. / de Graaf, H. / Wymenga, A. N. / Polee, M. / Hollema, H. et al. | 2012
- 2903
-
Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapyLybol, C. / Westerdijk, K. / Sweep, F. C. / Ottevanger, P. B. / Massuger, L. F. / Thomas, C. M. et al. | 2012
- 2907
-
ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinomaIlie, M. / Long, E. / Butori, C. / Hofman, V. / Coelle, C. / Mauro, V. / Zahaf, K. / Marquette, C. H. / Mouroux, J. / Paterlini-Brechot, P. et al. | 2012
- 2914
-
An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic settingGoto, K. / Satouchi, M. / Ishii, G. / Nishio, K. / Hagiwara, K. / Mitsudomi, T. / Whiteley, J. / Donald, E. / McCormack, R. / Todo, T. et al. | 2012
- 2919
-
Prophylactic cranial irradiation in small-cell lung cancer: Findings from a North Central Cancer Treatment Group Pooled AnalysisSchild, S. E. / Foster, N. R. / Meyers, J. P. / Ross, H. J. / Stella, P. J. / Garces, Y. I. / Olivier, K. R. / Molina, J. R. / Past, L. R. / Adjei, A. A. et al. | 2012
- 2925
-
A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancerHan, J. Y. / Nam, B. H. / Kim, H. Y. / Yoon, S. J. / Kim, H. T. / Lee, J. S. et al. | 2012
- 2931
-
Clinical outcome for EML4-ALK-positive patients with advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapyTakeda, M. / Okamoto, I. / Sakai, K. / Kawakami, H. / Nishio, K. / Nakagawa, K. et al. | 2012
- 2937
-
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factorHiltermann, T. J. / Pore, M. M. / van den Berg, A. / Timens, W. / Boezen, H. M. / Liesker, J. J. / Schouwink, J. H. / Wijnands, W. J. / Kerner, G. S. / Kruyt, F. A. et al. | 2012
- 2943
-
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?Mezynski, J. / Pezaro, C. / Bianchini, D. / Zivi, A. / Sandhu, S. / Thompson, E. / Hunt, J. / Sheridan, E. / Baikady, B. / Sarvadikar, A. et al. | 2012
- 2948
-
Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumorsKoning,, C. C. / Blank, L. E. / Koedooder, C. / van Os, R. M. / van de Kar, M. / Jansen, E. / Battermann, J. J. / Beijert, M. / Gernaat, C. / van Herpen, K. A. et al. | 2012
- 2953
-
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkins lymphomaSasse, S. / Klimm, B. / Gorgen, H. / Fuchs, M. / Heyden-Honerkamp, A. / Lohri, A. / Koch, O. / Wilhelm, M. / Trenn, G. / Finke, J. et al. | 2012
- 2960
-
Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGsNaing, A. / Veasey-Rodrigues, H. / Hong, D. S. / Fu, S. / Falchook, G. S. / Wheler, J. J. / Tsimberidou, A. M. / Wen, S. / Fessahaye, S. N. / Golden, E. C. et al. | 2012
- 2964
-
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)Duell, E. J. / Lucenteforte, E. / Olson, S. H. / Bracci, P. M. / Li, D. / Risch, H. A. / Silverman, D. T. / Ji, B. T. / Gallinger, S. / Holly, E. A. et al. | 2012
- 2970
-
Primary metastatic Ewings family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiationLuksch, R. / Tienghi, A. / Hall, K. S. / Fagioli, F. / Picci, P. / Barbieri, E. / Gandola, L. / Eriksson, M. / Ruggieri, P. / Daolio, P. et al. | 2012
- 2977
-
Comparison of absolute benefits of anticancer therapies determined by snapshot and area methodsSeruga, B. / Pond, G. R. / Hertz, P. C. / Amir, E. / Ocana, A. / Tannock, I. F. et al. | 2012
- 2983
-
Attributable causes of cancer in ChinaWang, J. B. / Jiang, Y. / Liang, H. / Li, P. / Xiao, H. J. / Ji, J. / Xiang, W. / Shi, J. F. / Fan, Y. G. / Li, L. et al. | 2012
- 2990
-
Lobular endocervical glandular hyperplasia and peritoneal pigmentation associated with Peutz-Jeghers syndrome due to a germline mutation of STK11Hirasawa, A. / Akahane, T. / Tsuruta, T. / Kobayashi, Y. / Masuda, K. / Banno, K. / Fujii, T. / Susumu, N. / Itsubo, T. / Kameyama, K. et al. | 2012
- 2990
-
Adjuvant endocrine therapy with tamoxifen: side-effects on the female genital tract are not always what they seemMourits, M. J. / Buijs, C. et al. | 2012
- 2992
-
Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancerThiery-Vuillemin, A. / Curtit, E. / Maurina, T. / Montange, D. / Succi, C. / NGuyen, T. / Kim, S. / Montcuquet, P. / Pivot, X. / Royer, B. et al. | 2012
- 2993
-
Meat consumption and cancer risk: is the definition of red meat always suitable?Lippi, G. / Mattiuzzi, C. et al. | 2012